Malcolm Brenner
Malcolm Brenner
Professor of Medicine, Baylor College of Medicine
Verified email at
Cited by
Cited by
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
EM Horwitz, DJ Prockop, LA Fitzpatrick, WWK Koo, PL Gordon, M Neel, ...
Nature medicine 5 (3), 309-313, 1999
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax, AE Foster, GG Wulf, JG Nuchtern, TW Jax, U Gobel, ...
Proceedings of the National Academy of Sciences 101 (39), 14228-14233, 2004
Inducible apoptosis as a safety switch for adoptive cell therapy
A Di Stasi, SK Tey, G Dotti, Y Fujita, A Kennedy-Nasser, C Martinez, ...
New England Journal of Medicine 365 (18), 1673-1683, 2011
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
CM Rooney, CYC Ng, S Loftin, CA Smith, C Li, RA Krance, MK Brenner, ...
The Lancet 345 (8941), 9-13, 1995
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus–induced lymphoma in allogeneic transplant recipients
CM Rooney, CA Smith, CYC Ng, SK Loftin, JW Sixbey, Y Gan, ...
Blood, The Journal of the American Society of Hematology 92 (5), 1549-1555, 1998
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, ...
Nature medicine 14 (11), 1264-1270, 2008
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, ...
Blood, The Journal of the American Society of Hematology 118 (23), 6050-6056, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
B Savoldo, CA Ramos, E Liu, MP Mims, MJ Keating, G Carrum, ...
The Journal of clinical investigation 121 (5), 1822-1826, 2011
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
MK Brenner, DR Rill, RA Krance, JN Ihle, RC Moen, J Mirro, WF Anderson
The Lancet 341 (8837), 85-86, 1993
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma
N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ...
Journal of clinical oncology 33 (15), 1688, 2015
Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
HE Heslop, CYC Ng, C Li, CA Smith, SK Loftin, RA Krance, MK Brenner, ...
Nature medicine 2 (5), 551-555, 1996
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, ...
Blood, The Journal of the American Society of Hematology 115 (5), 925-935, 2010
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof, MA Pule, P Yotnda, G Dotti, EF Vanin, MK Brenner, ...
Blood 105 (11), 4247-4254, 2005
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta
EM Horwitz, DJ Prockop, PL Gordon, WWK Koo, LA Fitzpatrick, MD Neel, ...
Blood, The Journal of the American Society of Hematology 97 (5), 1227-1231, 2001
HER2-specific chimeric antigen receptor–modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial
N Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ...
JAMA oncology 3 (8), 1094-1101, 2017
Design and development of therapies using chimeric antigen receptor‐expressing T cells
G Dotti, S Gottschalk, B Savoldo, MK Brenner
Immunological reviews 257 (1), 107-126, 2014
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ...
The Journal of clinical investigation 126 (8), 3036-3052, 2016
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
AM Leen, GD Myers, U Sili, MH Huls, H Weiss, KS Leung, G Carrum, ...
Nature medicine 12 (10), 1160-1166, 2006
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V Hoyos, B Savoldo, C Quintarelli, A Mahendravada, M Zhang, J Vera, ...
Leukemia 24 (6), 1160-1170, 2010
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013
The system can't perform the operation now. Try again later.
Articles 1–20